Panelists discuss how dermatologic toxicities from EGFR-targeted therapies can be effectively managed through a comprehensive approach combining prophylactic measures, early interventions with oral ...

Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

IIT-G and Bose Institute develop advanced injectable hydrogel for precise cancer treatment, minimizing side effects on ...

Doctors might call Ann Malik of Rhode Island an outlier; we would call her a thriver. Malik was diagnosed with stage four lung cancer at the age of 39, given just one month to live. Today, she is ten ...

Mutation-directed targeted therapy in combination with a PD-L1 inhibitor “is a promising strategy” to extend survival in patients with anaplastic thyroid cancer, according to researchers.

A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for ...

Guwahati, in collaboration with Bose Institute Kolkata, have developed an advanced injectable hydrogel designed for localised ...

A team of scientists from Indian Institute of Technology (IIT) Guwahati and Bose Institute Kolkata has developed an advanced ...

The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.